Julia T Arnold
Overview
Explore the profile of Julia T Arnold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gundeti M, Arnold J
J Ayurveda Integr Med
. 2024 Feb;
15(1):100907.
PMID: 38422820
No abstract available.
2.
Arnold J
J Ayurveda Integr Med
. 2022 Dec;
14(2):100676.
PMID: 36543691
Integration of Ayurveda into our current health care research programs is critical to making progress in global wellness and in disease prevention and control, especially for cancer. Ayurveda promotes restoration...
3.
Arnold J
J Ayurveda Integr Med
. 2022 Dec;
14(2):100677.
PMID: 36529638
The aim of this two-part review in this issue is to provide some basic perspectives from Ayurveda, the traditional medicine of India, and to discuss how current research methodologies may...
4.
Piao Y, Wiesenfeld P, Sprando R, Arnold J
J Steroid Biochem Mol Biol
. 2013 Jun;
138:206-13.
PMID: 23770322
The inflammatory tissue microenvironment can be an active promoter in preneoplastic cancer lesions. Altered steroid hormone metabolism as induced by the inflammatory microenvironment may contribute to epithelial cancer progression. Dehydroepiandrosterone...
5.
Vollmer G, Helle J, Amri H, Liu X, Arnold J
J Steroid Biochem Mol Biol
. 2011 Dec;
129(3-5):153-62.
PMID: 22207083
The reactive stromal phenotype is an important factor for prostate cancer progression and may be a new target for treatment and prevention. A new high efficiency preclinical protocol, the EPI...
6.
Liu X, Piao Y, Arnold J
Carcinogenesis
. 2011 Sep;
32(11):1648-54.
PMID: 21914638
Transforming growth factor β1 (TGF-β1) increases dehydro-epiandrosterone (DHEA) metabolism to androgens and prostate-specific antigen (PSA) in a prostate tissue model where stromal (6S) cells and epithelial (LAPC-4) cells are cocultured....
7.
Liu X, Choi R, Jawad S, Arnold J
Prostate
. 2010 Oct;
71(7):766-77.
PMID: 21031436
Background: Prostate cancer (PrCa) risk is positively associated with levels of insulin-like growth factor I (IGF-I) and prostate specific antigen (PSA), both androgen receptor (AR) signaling target genes in PrCa...
8.
Liu X, Arnold J, Blackman M
Endocrinology
. 2010 Feb;
151(4):1428-40.
PMID: 20176724
beta-Catenin/T-cell factor signaling (beta-CTS) plays multiple critical roles in carcinogenesis and is blocked by androgens in androgen receptor (AR)-responsive prostate cancer (PrCa) cells, primarily via AR sequestration of beta-catenin from...
9.
Gray N, Liu X, Choi R, Blackman M, Arnold J
Cancer Prev Res (Phila)
. 2009 Jan;
2(2):134-42.
PMID: 19141600
Dehydroepiandrosterone (DHEA) is used as a dietary supplement and can be metabolized to androgens and/or estrogens in the prostate. We investigated the hypothesis that DHEA metabolism may be increased in...
10.
Arnold J
Mol Cell Endocrinol
. 2008 Nov;
301(1-2):83-8.
PMID: 19013497
Dehydroepiandrosterone (DHEA) is commonly used in the USA as a nutritional supplement for antiaging, metabolic support or other uses. Investigations into understanding the effects of DHEA on human prostate cancer...